Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis
Authors:
- M HennenbergMHM Hennenberg
- J TrebickaJTJ Trebicka
- K JochemKJK Jochem
- L LeifeldLLL Leifeld
- E BieckerEBE Biecker
- T SauerbruchTST Sauerbruch
- J HellerJHJ Heller
Abstract
Background and aims: Portal hypertension in cirrhosis is mediated in part by increased intrahepatic resistance, reflecting an increased sensitivity of the hepatic microvasculature to vasoconstrictors. Activation of the RhoA/Rho-kinase pathway is essential for contraction of vascular smooth muscle. The aim of this study was to investigate RhoA/Rho-kinase mediated regulation of the intrahepatic vascular tone in cirrhotic rats. Methods: Cirrhosis was induced by bile duct ligation (BDL). Hepatic RhoA and Rho-kinase expressions were studied by real time reverse transcription polymerase chain reaction and western blot analysis. Hepatic Rho-kinase activity in rat and human livers was assessed as phosphorylation of the Rho-kinase substrate moesin. The effect of the Rho-kinase inhibitor Y-27632 on hepatic perfusion pressure was measured in livers perfused at constant flow. The in vivo effect of intravenous application of Y-27632 was studied by haemodynamic measurements. Results: Hepatic expressions of RhoA and Rho-kinase were increased at mRNA and protein level in BDL rats. Intrahepatic moesin phosphorylation was increased in livers from cirrhotic rats and patients with alcohol induced cirrhosis. Y-27632 reduced the basal perfusion pressure of in situ perfused livers in BDL rats but not in sham operated rats. Y-27632 reduced the sensitivity to methoxamine in isolated perfused livers in sham operated rats more than in BDL rats. In vivo, Y-27632 reduced portal pressure to a greater extent in BDL rats than in sham operated rats. Intrahepatic vascular resistance was decreased in response to bolus injection of Y-27632 in BDL rats but not in sham operated rats. Conclusions: Upregulation of RhoA and Rho-kinase contributes to increased intrahepatic resistance in cirrhotic rats and to an increased sensitivity of cirrhotic livers to vasoconstrictors.Keywords
This publication has 57 references indexed in Scilit:
- Increased Hepatic ResistanceJournal of Clinical Gastroenterology, 2005
- Prevention of ischemia–reperfusion-induced hepatic microcirculatory disruption by inhibiting stellate cell contraction using rock inhibitor1Transplantation, 2003
- Rho GTPases in cell biologyNature, 2002
- Lysophosphatidic Acid Enhances Collagen Gel Contraction by Hepatic Stellate Cells: Association with Rho-KinaseBiochemical and Biophysical Research Communications, 2000
- ROCK Inhibitor Y-27632 Attenuates Stellate Cell Contraction and Portal Pressure Increase Induced by Endothelin-1Biochemical and Biophysical Research Communications, 1999
- Enhanced Expression of CD80 (B7-1), CD86 (B7-2), and CD40 and Their Ligands CD28 and CD154 in Fulminant Hepatic FailureThe American Journal of Pathology, 1999
- Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic ratsHepatology, 1998
- Rho-Kinase Phosphorylates COOH-terminal Threonines of Ezrin/Radixin/Moesin (ERM) Proteins and Regulates Their Head-to-Tail AssociationJournal of Cell Biology, 1998
- The cellular pathogenesis of portal hypertension: Stellate cell contractility, endothelin, and nitric oxideHepatology, 1997
- Increased hepatic endothelin-1 levels and endothelin receptor density in cirrhotic ratsLife Sciences, 1995